fbpx
Medical Innovation Exchange

J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3

https://www.fiercebiotech.com/biotech/jj-backed-locus-closes-35m-financing-crispr-based-antimicrobial-drugs

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.